Yu-Kyeong Hwang
Director/Board Member bei GC CELL CORPORATION
Profil
Yu-Kyeong Hwang is currently the Director, Senior MD & Head-Research Institute at GC Cell Corp.
Prior to this, Dr. Hwang worked as a Director at GREEN CROSS CELL Corp.
and as a Director at Artiva Biotherapeutics, Inc. from 2019 to 2022.
Dr. Hwang completed their undergraduate degree at Indiana University.
Aktive Positionen von Yu-Kyeong Hwang
| Unternehmen | Position | Beginn |
|---|---|---|
| GC CELL CORPORATION | Director/Board Member | 01.09.2014 |
Ehemalige bekannte Positionen von Yu-Kyeong Hwang
| Unternehmen | Position | Ende |
|---|---|---|
Artiva Biotherapeutics, Inc.
 Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | Director/Board Member | 01.04.2022 |
| GREEN CROSS CELL CORPORATION | Director/Board Member | - |
Ausbildung von Yu-Kyeong Hwang
| Indiana University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| GC CELL CORPORATION | Health Technology |
| Private Unternehmen | 2 |
|---|---|
GREEN CROSS CELL Corp.
 GREEN CROSS CELL Corp. BiotechnologyHealth Technology GREEN CROSS CELL Corp. engages in the provision of anti-cancer immunotherapy. It operates through the following businesses: Cancer Immunotherapy, Cord Blood Cryopreservation, and Other Services. The company was founded on September 17, 1992 and is headquartered in Yongin-si, South Korea. | Health Technology |
Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | Health Technology |
